17 February 2021

Antimicrobial resistance (AMR) is one of the most significant threats to society. The One Health approach considers all aspects of AMR including clinical, farmed and ‘natural’ environments. However, the natural environment (for example, rivers and streams), though heavily impacted by human activities, is still the least well studied.

For example, 11 billion litres of wastewater are treated every day in the UK. Wastewater contains active antimicrobial compounds such as antibiotics, which can promote the evolution of AMR. Research has shown that these low concentrations of antibiotics are enough to increase levels of AMR in laboratory experiments. Our research with AstraZeneca has gone further to show that this occurs in complex communities of bacteria derived from sewage and that low, environmentally relevant concentrations of one clinically important antibiotic can even increase levels of AMR to the same extent as clinically relevant concentrations [1].

This evidence demonstrates the environment is important, but the release of antibiotics and antimicrobials into the environment is not currently regulated. Regulation requires evidence that antibiotics at environmental concentrations pose a risk, but current experimental methods only look at the toxicity risk antibiotics pose to aquatic organisms, rather than focusing on AMR.

Further reading: Microbiology Society
Author(s): Aimee Kaye Murray
Clean Environment  


Unrestricted financial support by:

Antimicrobial Resistance Fighter Coalition


JSS University


Technology Database

Display your AMR Technology, Product and Service

Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.

Read more and make your own Technology Page >>
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!